| Application no. and date | 17859451.1 (espacenet) (Federated) (European Patent Register), 20171012 | | Patent/reg. no. and date | DK/EP 3525583, 20250723 | | Publication date | 20190821 | | Priority no. and date | US 201662407390 P, 20161012 | | EP pub. no. and date |
EP 3525583 20190821 | | Effective date | | | Applicant/owner | Bioverativ USA Inc., 225 Second Avenue
Waltham, MA 02451, US | | Applicant ref. no. | 2031800 | | Inventor | PARRY, Graham, 951 Gateway Boulevard
South San Francisco, CA 94080, US,
STAGLIANO, Nancy, E., 951 Gateway Boulevard
South San Francisco, CA 94080, US,
PANICKER, Sandip, 951 Gateway Boulevard
South San Francisco, CA 94080, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61B 5/055 (2006.01) , A61K 39/395 (2006.01) , A61P 43/00 (2006.01) , C07K 16/18 (2006.01) | | Title | ANTI-C1S-ANTISTOFFER OG FREMGANGSMÅDER TIL ANVENDELSE DERAF | | Int. application no. | US2017056349 | | Int. publication no. | WO2018071676 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
